Merrimack Pharmaceuticals Inc: DEFA14A filed Mar 27, 2024

Form type

DEFA14A

Filing date

Mar 27, 2024

Accession number

0001193125-24-078920

Filer

Merrimack Pharmaceuticals Inc (CIK 1274792)